1. 119532-26-2
2. 1-(2,3-dichlorophenyl)piperazine Monohydrochloride
3. 1-(2,3-dichlorophenyl)piperazine Hcl
4. 1-(2,3-dichlorophenyl)piperazine;hydrochloride
5. 1-(2,3-dichlorophenyl)-piperazine Hydrochloride
6. 1-(2,3-dichlorophenyl)piperazine, Hcl
7. Aripiprazole Related Compound C
8. Mfcd00190238
9. Piperazine, 1-(2,3-dichlorophenyl)-, Monohydrochloride
10. N-(2,3-dichlorophenyl)piperazine Hydrochloride
11. 1-(2,3-dichloorphenyl)piperazine Hcl
12. 1-(2,3-dichlorophenyl)-piperazine Monohydrochloride
13. 2,3-dichlorophenylpiperazine Hydrochloride
14. 1-(2,3-dichlorophenyl)piperazinehydrochloride
15. Ec 601-621-5
16. Schembl246338
17. Amy3595
18. Dtxsid50866037
19. Act02157
20. Bcp08858
21. Lt0049
22. Akos015845866
23. Ac-7247
24. Cs-w023109
25. As-10761
26. Sy005342
27. 2,3-dichlorophenyl Piperazine Hydrochloride
28. 2,3-dichlorophenyl-piperazine Hydrochloride
29. D3660
30. Ft-0600910
31. 1-(2,3-dichlorophenyl)-piperazine Hydrochlorid
32. 1-(2,3-dichloro-phenyl)piperazine Hydrochloride
33. 1-(2,3-dichlorophenyl)piperazine, Hydrochloride
34. 1-(2,3-dichloro-phenyl)-piperazine Hydrochloride
35. 1-(2,3-diclorophenyl)piperazine Monohydrochloride
36. A926926
37. 1-(2,3-dichlorophenyl)piperazine Hydrochloride Salt
38. 1-(2,3-dichlorophenyl)piperazine Mono Hydrochloride
39. J-502893
40. J-502894
41. 1-(2,3-dichlorophenyl)piperazine Hydrochloride, 97%
42. F2190-0526
43. Piperazine, 1-(2,3-dichlorophenyl)-, Hydrochloride (1:1)
44. Aripiprazole Related Compound C, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 267.6 g/mol |
|---|---|
| Molecular Formula | C10H13Cl3N2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 266.014432 g/mol |
| Monoisotopic Mass | 266.014432 g/mol |
| Topological Polar Surface Area | 15.3 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 183 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
BUILDING BLOCK
END USE APIs
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Aptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
Chongqing Sintaho Pharma: A trusted partner globally for chemosynthetic APIs.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Hubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.
Porton Pharma Solutions: Value creation via innovation & discovery through technical platforms.
RELATED INTERMEDIATES
LOOKING FOR A SUPPLIER?
